CD44 is the physiological trigger of Fas up-regulation on rheumatoid synovial cells

被引:60
作者
Fujii, K
Fujii, Y
Hubscher, S
Tanaka, Y
机构
[1] Univ Occupat & Environm Hlth, Sch Med, Dept Internal Med 1, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan
[2] Univ Birmingham, Dept Pathol, Birmingham, W Midlands, England
关键词
D O I
10.4049/jimmunol.167.3.1198
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD44 is a ubiquitous molecule known as a hyaluronan receptor. However, the relevance of CD44 to inflammatory processes, for example, rheumatoid synovitis, remains unclear. In this study, we propose a novel function for CD44 using synovial cells from rheumatoid arthritis (RA) patients and demonstrated that CD44 cross-linking augmented Fas expression and subsequent Fas-mediated apoptosis of the cells: 1) cross-linking of CD44 on RA synovial cells markedly augmented Fas expression and its mRNA transcription; 2) engagement of CD44 up-regulated Fas on the cells within 3 h, much more than IL-1 beta and TNF-alpha did; 3) the Fas-mediated early apoptotic change of the cells was amplified by CD44 cross-linking; and 4) hyaluronan, especially when fragmented, also augmented Fas-mediated early apoptosis of the cells. Based on these findings, we postulate a new concept: that interaction of CD44 on RA synovial cells with hyaluronan fragments present in the surrounding extracellular matrix augments Fas expression as well as Fas-mediated apoptosis of synovial cells. This may lead to spontaneous growth arrest through Fas-Fas ligand pathway observed in synovial cells of RA synovitis in vivo.
引用
收藏
页码:1198 / 1203
页数:6
相关论文
共 40 条
[1]   ALTERED T-LYMPHOCYTE SIGNALING IN RHEUMATOID-ARTHRITIS [J].
ALLEN, ME ;
YOUNG, SP ;
MICHELL, RH ;
BACON, PA .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (06) :1547-1554
[2]  
Aupperle KR, 1998, AM J PATHOL, V152, P1091
[3]   HYALURONIC ACID IN SYNOVIAL FLUID .I. MOLECULAR PARAMETERS OF HYALURONIC ACID IN NORMAL AND ARTHRITIC HUMAN FLUIDS [J].
BALAZS, EA ;
WATSON, D ;
DUFF, IF ;
ROSEMAN, S .
ARTHRITIS AND RHEUMATISM, 1967, 10 (04) :357-&
[4]  
Choy EHS, 1998, BRIT J RHEUMATOL, V37, P484
[5]   TREATMENT OF RHEUMATOID-ARTHRITIS WITH SINGLE DOSE OR WEEKLY PULSES OF CHIMERIC ANTI-CD4 MONOCLONAL-ANTIBODY [J].
CHOY, EHS ;
CHIKANZA, IC ;
KINGSLEY, GH ;
CORRIGALL, V ;
PANAYI, GS .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1992, 36 (02) :291-298
[6]   CONCENTRATION AND MOLECULAR-WEIGHT OF SODIUM HYALURONATE IN SYNOVIAL-FLUID FROM PATIENTS WITH RHEUMATOID-ARTHRITIS AND OTHER ARTHROPATHIES [J].
DAHL, LB ;
DAHL, IMS ;
ENGSTROMLAURENT, A ;
GRANATH, K .
ANNALS OF THE RHEUMATIC DISEASES, 1985, 44 (12) :817-822
[7]   Rheumatoid arthritis [J].
Feldmann, M ;
Brennan, FM ;
Maini, RN .
CELL, 1996, 85 (03) :307-310
[8]  
Fine A, 1998, J CELL PHYSIOL, V174, P285, DOI 10.1002/(SICI)1097-4652(199803)174:3<285::AID-JCP2>3.0.CO
[9]  
2-K
[10]   APOPTOSIS IN RHEUMATOID-ARTHRITIS SYNOVIUM [J].
FIRESTEIN, GS ;
YEO, M ;
ZVAIFLER, NJ .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (03) :1631-1638